Results 11 to 20 of about 71,751 (203)
Chinese Journal of Lung Cancer, 2021 Small cell lung cancer (SCLC) is the most malignant lung cancer with the highest mortality. At present, the first-line standard treatment is still based on Etoposide and Platinum chemotherapy.
Zihan QU +5 more
doaj +1 more source
Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer
Frontiers in Oncology, 2021 The clinical application of immunotherapy is the milestone of cancer treatment. However, some patients have bad reaction. Cyclooxygenase-2 (COX-2) is frequently expressed in multiple cancer cells and is associated with poor prognosis.
Dan Pu +8 more
doaj +1 more source
EGFR-TKI ADR Management Chinese Expert Consensus
Chinese Journal of Lung Cancer, 2019 ErbB receptor tyrosine kinase inhibitors (EGFR-TKI), gefitinib, erlotinib, icotinib and aftinib, which are approved as a frontline treatment for patients with non-small cell lung cancer (NSCLC) who have tumors harboring EGFR mutations in China.
Chinese Society of Lung Cancer, Chinese Anti-Cancer Association
doaj +1 more source
Thoracic Cancer, 2021 Background Lung cancer, mainly non‐small cell lung cancer (NSCLC), is one of the leading causes of death worldwide. Currently, chemotherapy is still the most significant treatment strategy for NSCLC.
Jinghao Liu +11 more
doaj +1 more source
Research Progress of Epigenetics in Pathogenesis and Treatment of Malignant Tumors
Chinese Journal of Lung Cancer, 2020 Epigenetic modification is closely related to the occurrence and development of tumors. It mainly regulates gene function and expression level through DNA methylation, histone modification, regulation of non-coding RNA and chromatin structure ...
Pan WANG +10 more
doaj +1 more source
BMC Pulmonary Medicine, 2021 Background The echinoderm microtubule-associated protein-like-4 anaplastic lymphoma kinase (EML4-ALK) fusion gene was identified in a subset of non-small cell lung cancer (NSCLC) patients. They responded positively to ALK inhibitors.
Ying Li +6 more
doaj +1 more source
Primary chondroma of posterior mediastinum with Horner’s syndrome: a case report
World Journal of Surgical Oncology, 2018 Background Chondroma is a slowly growing, benign cartilaginous tumor which predominantly occurs in long bones of the hands and feet. Primary mediastinal chondroma is rare, especially with Horner’s syndrome.
Xiaoqian Xu +5 more
doaj +1 more source
Medical Clinics of North America, 2019 Lung cancer is the world's leading cause of cancer death. Screening for lung cancer by low-dose computed tomography improves mortality. Various modalities exist for diagnosis and staging. Treatment is determined by subtype and stage of cancer; there are several personalized therapies that did not exist just a few years ago.
Faria, Nasim +2 more
openaire +5 more sources
Acta Oncologica, 1996 This synthesis of the literature on radiotherapy for lung cancer is based on 80 scientific articles, including 2 meta-analyses, 29 randomized studies, 19 prospective studies, and 21 retrospective studies. These studies involve 28172 patients. Basic treatment for limited-stage small cell lung cancer (SCLC), is chemotherapy.
openaire +2 more sources
A retrospective stenting study on superior vena cava syndrome caused by lung cancer
Thoracic Cancer, 2020 Background Superior vena cava syndrome (SVCS) is a common condition predominantly caused by lung cancer. The presence of symptoms of SVCS, such as elevated intracranial pressure and laryngeal edema, indicates an unfavorable prognosis for lung cancer ...
Sen Wei +8 more
doaj +1 more source